washingtonpost.com > Business > Local Business
Your Comments On...

MedImmune Settles Patent Lawsuit With Genentech

Biotechnology firms MedImmune and Genentech settled a lawsuit over a patented component of Synagis, MedImmune's best-selling drug, which is aimed at preventing respiratory infections in infants.
 - 

By Kendra Marr

 
Comments
© 2008 The Washington Post Company